Key result
Direct substrate assessment in HCM reveals arrhythmogenic mechanisms to refine sudden cardiac death risk.
Why the study?
Mechanisms driving ventricular arrhythmia in HCM remain incompletely understood, and traditional SCD risk prediction models often overlook specific arrhythmic substrates.
Direct assessment of arrhythmogenic substrates in hypertrophic cardiomyopathy offers a promising avenue to personalize and improve sudden cardiac death risk stratification beyond traditional clinical models.
Sudden cardiac death (SCD), the most devastating complication of hypertrophic cardiomyopathy (HCM), is primarily triggered by ventricular tachycardia or fibrillation. Despite advances in knowledge, the mechanisms driving ventricular arrhythmia in HCM remain incompletely understood, stemming from an interplay of multiple pro-arrhythmic factors. Myocyte disarray and myocardial fibrosis form a structural substrate favorable to re-entrant arrhythmias by altering myocardial electrophysiological properties, while cellular abnormalities predominate in patients without evident structural remodeling. Traditional SCD risk prediction models rely on clinical risk factors and regression-based risk estimation, often overlooking specific arrhythmic substrates. Emerging techniques now allow for the direct assessment of these substrates, providing deeper insights into the arrhythmogenic mechanisms and paving the way for more personalized SCD risk stratification. This review explores the contribution of cellular, structural, and electrophysiological substrates to arrhythmic risk in HCM, emphasizing their distinct roles. Furthermore, it highlights the potential of substrate-based approaches to refining SCD prevention strategies and improving outcomes for patients with HCM.
No takes yet. Share an insight, caveat, or question.
Sclafani et al. (2025) conducted a review in Hypertrophic Cardiomyopathy. Direct assessment of cellular, structural, and electrophysiological substrates in hypertrophic cardiomyopathy provides deeper insights into arrhythmogenic mechanisms to refine sudden cardiac death risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: